ARS Pharmaceuticals, Inc.(SPRY)
$8.30▲0.19 (2.34%)
ARS Pharmaceuticals, Inc.(SPRY)
NASDAQ
$8.30▲0.19 (2.34%)
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.86
Net Income/Share$-1.74
Operating CF/Share$-1.73
Free CF/Share$-1.74
Cash/Share$2.49
Book Value/Share$1.16
Tangible Book/Share$1.01
Equity/Share$1.16
Interest Debt/Share$0.98
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$824.17M
Enterprise Value$879.81M
P/E Ratio-4.78P/S Ratio9.78P/OCF Ratio-4.79
P/FCF Ratio-4.81
P/B Ratio7.16P/TB Ratio7.16
EV/Sales10.44EV/EBITDA-5.13
Graham Valuation
Graham Number--
Graham Net-Net$0.56
Profitability
Earnings Yield-20.94%FCF Yield-20.77%ROE-100.29%ROIC-62.04%Return on Tangible Assets-54.69%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-0.20%
CapEx/Revenue0.40%
CapEx/Depreciation-0.57
SBC/Revenue26.22%
SG&A/Revenue224.28%
R&D/Revenue15.64%
Liquidity & Solvency
Debt/Equity0.85Debt/Assets0.30Debt/Market Cap0.12
Net Debt/EBITDA-0.32
Current Ratio7.28Interest Coverage0.00xIncome Quality1.00Efficiency
Days Sales Outstanding110 days
Days Payables Outstanding102 days
Days Inventory150 days
Receivables Turnover3.32x
Payables Turnover3.57x
Inventory Turnover2.44x
Capital Structure
Tangible Assets$99.81M
Working Capital$245.75M
Invested Capital$262.67M
Intangibles/Assets4.41%